Propranolol in thyrotoxicosis: II. Serum thyroid hormone concentrations during subtotal thyroidectomy

Area of Science:

• Endocrinology
• Surgical Oncology
• Pharmacology

Background:

• Thyrotoxicosis management often involves surgical intervention.
• Preoperative preparation is crucial to minimize surgical risks.
• Beta-blockers like propranolol are commonly used to control hyperthyroid symptoms.

Purpose of the Study:

• To evaluate the efficacy and safety of propranolol as a sole agent for preoperative preparation in thyrotoxic patients undergoing subtotal thyroidectomy.
• To assess the impact of propranolol on thyroid hormone levels during and after surgery.
• To determine the incidence of complications and long-term outcomes.

Main Methods:

• Twenty thyrotoxic patients received propranolol as the sole preoperative medication.
• Serum thyroxine (T4) and triiodothyronine (T3) levels were monitored before, during, and after surgery.
• Cardiovascular response was used to guide propranolol dosage.
• Postoperative outcomes, including hypoparathyroidism and hypothyroidism, were recorded.

Main Results:

• Propranolol effectively controlled cardiovascular symptoms in preparation for surgery.
• No significant changes in T4 or T3 levels were detected during surgical manipulation.
• Postoperative thyroid hormone levels decreased significantly by discharge.
• Transient hypoparathyroidism occurred in four patients; long-term, two had permanent hypoparathyroidism and four developed hypothyroidism.

Conclusions:

• Propranolol can be used as a single agent to rapidly and safely prepare thyrotoxic patients for subtotal thyroidectomy.
• Surgical manipulation of the thyroid gland did not lead to a detectable release of thyroid hormones into circulation when patients were adequately prepared with propranolol.
• While generally safe, potential long-term complications like hypothyroidism and hypoparathyroidism require monitoring.